Dr. Mikhail on Ongoing Trials in Multiple Myeloma

Sameh Mikhail, MD
Published: Friday, Dec 01, 2017



Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discussing ongoing trials for patients with multiple myeloma.

According to Mikhail, many studies are looking at the inclusion of stem-cell transplants in patients with myeloma. Currently, there are many immune-modulatory agents and combinations that are being evaluated.

Immunotherapy continues to be an area of investigation in this patient population. Safety concerns are still being investigated, states Mikhail.
 


Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discussing ongoing trials for patients with multiple myeloma.

According to Mikhail, many studies are looking at the inclusion of stem-cell transplants in patients with myeloma. Currently, there are many immune-modulatory agents and combinations that are being evaluated.

Immunotherapy continues to be an area of investigation in this patient population. Safety concerns are still being investigated, states Mikhail.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Oncology Briefings™: Overcoming Chronic Iron Overload in Pediatric AML and MDSJun 30, 20181.0
Publication Bottom Border
Border Publication
x